Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methamphetamine Use and Cardiovascular Disease
Christopher G. Kevil, Nicholas E. Goeders, Matthew D. Woolard, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 9, pp. 1739-1746
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

Is Cardiovascular Disease Slowing Improvements in Life Expectancy?

(2020)
Closed Access | Times Cited: 431
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder
Martin P. Paulus, Jennifer L. Stewart
JAMA Psychiatry (2020) Vol. 77, Iss. 9, pp. 959-959
Open Access | Times Cited: 208
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
David Brieger, Louise Cullen, Tom Briffa, et al.
Heart Lung and Circulation (2025) Vol. 34, Iss. 4, pp. 309-397
Open Access | Times Cited: 2
Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts
Atul P. Daiwile, Subramaniam Jayanthi, Jean Lud Cadet
Neuroscience & Biobehavioral Reviews (2022) Vol. 137, pp. 104674-104674
Open Access | Times Cited: 51
Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database
Li‐Tzy Wu, Dan Zhao, Yue Lan, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption
Jong Su Hwang, Tam Thuy Lu Vo, Mi Kyung Kim, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 340-340
Open Access | Times Cited: 1
Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review
Pavan Reddy, Tien M. H. Ng, Esther E Oh, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 11
Open Access | Times Cited: 63
Escalating dose-multiple binge methamphetamine treatment elicits neurotoxicity, altering gut microbiota and fecal metabolites in mice
Lijian Chen, Xu Zhi, Kai-Kai Zhang, et al.
Food and Chemical Toxicology (2020) Vol. 148, pp. 111946-111946
Closed Access | Times Cited: 55
Mitochondrial Dysfunction and Heart Disease: Critical Appraisal of an Overlooked Association
Giandomenico Bisaccia, Fabrizio Ricci, Sabina Gallina, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 614-614
Open Access | Times Cited: 53
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Chowdhury S. Abdullah, Richa Aishwarya, Shafiul Alam, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Stimulant Drugs of Abuse and Cardiac Arrhythmias
Paari Dominic, Javaria Ahmad, Hajra Awwab, et al.
Circulation Arrhythmia and Electrophysiology (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies
Prabhat Shrestha, Nikita Katila, Sooyeun Lee, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113591-113591
Open Access | Times Cited: 34
Methamphetamine Induces Systemic Inflammation and Anxiety: The Role of the Gut–Immune–Brain Axis
Majid Davidson, M Mayer, Amanda Habib, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11224-11224
Open Access | Times Cited: 30
Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
Amber N. Edinoff, Sarah E. Kaufman, Keionne M. Green, et al.
Health psychology research (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 29
Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases
Francisco Javier Munguía-Galaviz, Alejandra Guillermina Miranda‐Díaz, Miguel Alejandro Cardenas-Sosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1997-1997
Open Access | Times Cited: 22
Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy
Yuqiao Liu, Junmin Li, Shenghao Xiao, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 726-726
Open Access | Times Cited: 22
Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective
Shanshan Chen, Wenhua Zhou, Miaojun Lai
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 334-334
Open Access | Times Cited: 8
Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users
Zaki Al‐Yafeai, Shafaqat Ali, Jimmy Brown, et al.
JACC Advances (2024) Vol. 3, Iss. 7, pp. 100840-100840
Open Access | Times Cited: 7
Methamphetamine‐Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities
Stephen Dickson, Isac C. Thomas, Harpreet Bhatia, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 16
Open Access | Times Cited: 35
Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008–2018
Leslie W. Suen, Thibaut Davy-Méndez, Kathy T. LeSaint, et al.
BMC Emergency Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Drugs of Misuse: Focus on Vascular Dysfunction
Holly R. Middlekauff, Ziva D. Cooper, Sasha B. Strauss
Canadian Journal of Cardiology (2022) Vol. 38, Iss. 9, pp. 1364-1377
Open Access | Times Cited: 26
Methamphetamine-associated heart failure: a systematic review of observational studies
Veena Manja, Ananya Nrusimha, Ya Gao, et al.
Heart (2022) Vol. 109, Iss. 3, pp. 168-177
Closed Access | Times Cited: 25
Overview of blood-brain barrier dysfunction in methamphetamine abuse
Lu Pang, Yun Wang
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114478-114478
Open Access | Times Cited: 15
Stimulant and hallucinogenic novel psychoactive substances; an update
Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1109-1123
Open Access | Times Cited: 14
Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study
Ursula S. Sandau, E. Duggan, Xiao Shi, et al.
Journal of Extracellular Vesicles (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top